Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Learoyd

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Endocrinology|September 24, 2005
PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growthAmy Y M Au, Claire McBride, Kenneth G Wilhelm, et al.
American Journal of Surgery|September 4, 2020
Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancerCarolina Nylén, Frida Bragvad Eriksson, Anna Yang, et al.
Annals of Surgical Oncology|May 25, 2021
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
European Journal of Endocrinology|September 6, 2002
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidismAndrea Villablanca, Wassif S Wassif, Thomas Smith, et al.
Annals of Surgical Oncology|May 23, 2025
Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid CancerPascal K C Jonker, Jan H Koetje, John Turchini, et al.
The American Journal of Surgical Pathology|September 17, 2016
NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2Jessica Reagh, Martyn Bullock, Juliana Andrici, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2016
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid CancerIain J Nixon, Laura Y Wang, Jocelyn C Migliacci, et al.
Cancer Research|April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-outHartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Endocrinology|September 24, 2005
PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growthAmy Y M Au, Claire McBride, Kenneth G Wilhelm, et al.
American Journal of Surgery|September 4, 2020
Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancerCarolina Nylén, Frida Bragvad Eriksson, Anna Yang, et al.
Annals of Surgical Oncology|May 25, 2021
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited TreatmentPascal K C Jonker, John Turchini, Schelto Kruijff, et al.
European Journal of Endocrinology|September 6, 2002
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidismAndrea Villablanca, Wassif S Wassif, Thomas Smith, et al.
Annals of Surgical Oncology|May 23, 2025
Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid CancerPascal K C Jonker, Jan H Koetje, John Turchini, et al.
The American Journal of Surgical Pathology|September 17, 2016
NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2Jessica Reagh, Martyn Bullock, Juliana Andrici, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2016
An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid CancerIain J Nixon, Laura Y Wang, Jocelyn C Migliacci, et al.
Cancer Research|April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-outHartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Pageof 3